Effect of treatment with carteolol and latanoprost in newly diagnosed primary open-angle glaucoma on peripapillary vessel density.

IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Jan Lestak, Martin Fus, Sarka Pitrova
{"title":"Effect of treatment with carteolol and latanoprost in newly diagnosed primary open-angle glaucoma on peripapillary vessel density.","authors":"Jan Lestak, Martin Fus, Sarka Pitrova","doi":"10.5507/bp.2024.010","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>In a previous follow-up of glaucoma patients taking carteolol or latanoprost, we found a greater progression of visual field changes with the prostaglandin than the betablocker. In the present study we compared the impact of carteolol and latanoprost on peripapillary vessel density in newly diagnosed primary open-angle glaucoma (POAG) patients.</p><p><strong>Methods: </strong>The study consisted of two groups of POAG patients. There were 46 patient eyes treated with carteolol (Carteol LP 2%) in the first group and 52 eyes treated with latanoprost (Xalatan 0.005%) in the second. Intraocular pressure (IOP), vessel density (VD) and visual field were assessed in all patients. VD was measured peripapillary by optical coherence tomography angiography (OCTA) with the Avanti RTVue XR in eight segments: Inferior Temporal - IT (1); Temporal Inferior -TI (2); Temporal Superior - TS (3); Superior Temporal - ST (4); Superior Nasal - SN (5); Nasal Superior - NS (6); Nasal Inferior - NI (7) and Inferior Nasal - IN (8). The measurements were compared before and after three months of treatment. The visual field was examined with a fast threshold glaucoma program using a Medmont M 700 instrument from Medmont International Pty Ltd. and only when a diagnosis of POAG was done. The overall defect (OD) was assessed.</p><p><strong>Results: </strong>Before treatment, there was no difference between groups in either OD or VD. After treatment, there was a decrease in IOP in both groups. In the carteolol-treated group, the mean decrease was 5.8 mmHg and in the latanoprost-treated eyes, the mean decrease was 7 mmHg. The difference was not statistically significant (P=0.133). After treatment with carteolol, there was a statistically significant increase in VD in segments 4, 5 and 6. After latanoprost treatment, VD was statistically significantly improved only in segment 5. A greater increase in VD values was found in eyes treated with carteolol than in eyes treated with latanoprost.</p><p><strong>Conclusion: </strong>Carteolol had a better effect on vessel density than latanoprost.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Papers-Olomouc","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5507/bp.2024.010","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim: In a previous follow-up of glaucoma patients taking carteolol or latanoprost, we found a greater progression of visual field changes with the prostaglandin than the betablocker. In the present study we compared the impact of carteolol and latanoprost on peripapillary vessel density in newly diagnosed primary open-angle glaucoma (POAG) patients.

Methods: The study consisted of two groups of POAG patients. There were 46 patient eyes treated with carteolol (Carteol LP 2%) in the first group and 52 eyes treated with latanoprost (Xalatan 0.005%) in the second. Intraocular pressure (IOP), vessel density (VD) and visual field were assessed in all patients. VD was measured peripapillary by optical coherence tomography angiography (OCTA) with the Avanti RTVue XR in eight segments: Inferior Temporal - IT (1); Temporal Inferior -TI (2); Temporal Superior - TS (3); Superior Temporal - ST (4); Superior Nasal - SN (5); Nasal Superior - NS (6); Nasal Inferior - NI (7) and Inferior Nasal - IN (8). The measurements were compared before and after three months of treatment. The visual field was examined with a fast threshold glaucoma program using a Medmont M 700 instrument from Medmont International Pty Ltd. and only when a diagnosis of POAG was done. The overall defect (OD) was assessed.

Results: Before treatment, there was no difference between groups in either OD or VD. After treatment, there was a decrease in IOP in both groups. In the carteolol-treated group, the mean decrease was 5.8 mmHg and in the latanoprost-treated eyes, the mean decrease was 7 mmHg. The difference was not statistically significant (P=0.133). After treatment with carteolol, there was a statistically significant increase in VD in segments 4, 5 and 6. After latanoprost treatment, VD was statistically significantly improved only in segment 5. A greater increase in VD values was found in eyes treated with carteolol than in eyes treated with latanoprost.

Conclusion: Carteolol had a better effect on vessel density than latanoprost.

使用卡替洛尔和拉坦前列素治疗新诊断的原发性开角型青光眼对毛细血管周围密度的影响。
背景和目的:在之前对服用卡替洛尔或拉坦前列腺素的青光眼患者进行的随访中,我们发现前列腺素的视野变化进展大于受体阻滞剂。在本研究中,我们比较了卡替洛尔和拉坦前列素对新诊断的原发性开角型青光眼(POAG)患者毛细血管周围密度的影响:研究包括两组 POAG 患者。方法:该研究由两组POAG患者组成,第一组46只眼睛接受卡替洛尔(Carteolol LP 2%)治疗,第二组52只眼睛接受拉坦前列素(Xalatan 0.005%)治疗。对所有患者的眼压(IOP)、血管密度(VD)和视野进行了评估。用 Avanti RTVue XR 光学相干断层血管造影(OCTA)测量了八个节段的毛细血管密度:颞下部 - IT (1);颞下部 -TI (2);颞上部 - TS (3);颞上部 - ST (4);鼻上部 - SN (5);鼻上部 - NS (6);鼻下部 - NI (7)和鼻下部 - IN (8)。治疗前后三个月的测量结果进行了比较。使用 Medmont International Pty Ltd. 公司的 Medmont M 700 仪器,用快速阈值青光眼程序检查视野,只有在确诊为 POAG 时才进行检查。结果:结果:治疗前,各组的 OD 或 VD 均无差异。治疗后,两组患者的眼压都有所下降。卡替洛尔治疗组的平均降幅为 5.8 mmHg,而拉坦前列素治疗组的平均降幅为 7 mmHg。差异无统计学意义(P=0.133)。使用卡替洛尔治疗后,第 4、5 和 6 节段的 VD 有统计学意义的显著增加。拉坦前列腺素治疗后,只有第 5 节段的 VD 有明显的统计学改善。与使用拉坦前列腺素治疗的眼睛相比,使用卡替洛尔治疗的眼睛VD值的增加幅度更大:结论:卡替洛尔对血管密度的影响优于拉坦前列素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biomedical Papers-Olomouc
Biomedical Papers-Olomouc MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.30
自引率
0.00%
发文量
74
审稿时长
6-12 weeks
期刊介绍: Biomedical Papers is a journal of Palacký University Olomouc, Faculty of Medicine and Dentistry, Olomouc, Czech Republic. It includes reviews and original articles reporting on basic and clinical research in medicine. Biomedical Papers is published as one volume per year in four issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信